Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2012
06/07/2012US20120141467 Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
06/07/2012US20120141464 Binding member for gm-csf receptor
06/07/2012US20120141463 Method Of Identifying Membrane Ig Specific Antibodies And Use Thereof For Targeting Immunoglobulin-Producing Precursor Cells
06/07/2012US20120141457 Lateral Flow Immunoassay for Complement Activation and Methods of Use for Point-of-Care Assessment of Complement-Associated Disorders
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141443 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
06/07/2012US20120141401 Soft anticholinergic zwitterions
06/07/2012CA2819854A1 Nitric oxide treatments
06/07/2012CA2819619A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819508A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/06/2012EP2460806A1 Nitrogen-containing spiro-ring compound and medicinal use of same
06/06/2012EP2460805A1 Fused imidazole derivative having ttk inhibitory action
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2459572A2 Spirocyclic amide derivatives
06/06/2012EP2459556A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors
06/06/2012EP2459541A1 Dihydropyrimidone amides as p2x7 modulators
06/06/2012EP2459189A1 Fatty acids as anti-inflammatory agents
06/06/2012EP2196475B1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
06/06/2012EP1616575B1 Method for treating inflammation
06/06/2012CN202263199U Compound Clarinex pseudoephedrine sulfate sustained release tablet pharmaceutical composition
06/06/2012CN1935839B Analogues of GLP-1
06/06/2012CN102485717A Thiazolamine derivative and application thereof as sRNA virus infection resisting medicine
06/06/2012CN102485267A Tibetan-Miao medicine for treating child cough caused by allergy, viruses, and bacteria
06/06/2012CN102485265A Traditional Chinese medicine composition for clearing heat, removing toxins, benefiting throat and relieving pain and a preparation method thereof
06/06/2012CN102485264A Pharmaceutical composition for treating children's long-term cough and preparation method thereof
06/06/2012CN102485263A Medicinal composition for treating chronic cough of children and its preparation method
06/06/2012CN102485262A Traditional Chinese medicine composition with characteristics of clearing heat, detoxifying and relieving throat pain as well as its preparation method
06/06/2012CN102485257A Chinese medicinal composition with lung ventilating, stagnated qi dispersing, heat clearing and phlegm eliminating effects and its preparation method
06/06/2012CN102485256A Chinese medicine composition for diffusing lung, depressing qi, clearing heat, and eliminating phlegm and preparation method thereof
06/06/2012CN102485242A Chinese medicinal composition for dispelling wind, clearing heat, removing toxins, and benefiting throat, and preparation method thereof
06/06/2012CN102485241A Traditional Chinese medicine composition having functions of dispelling wind, clearing heat, removing toxins and benefiting throat and preparation method thereof
06/06/2012CN102205014B Method for processing rhizoma arisaematis
06/06/2012CN102091227B Chinese medicinal preparation for treating swelling and pain in throat and preparation method thereof
06/06/2012CN101991805B Medicament for treating trachitis
06/06/2012CN101979066B Atomized liquid for stopping asthma and eliminating phlegm and preparation method thereof
06/06/2012CN101954022B Chinese medicinal composition for treating lung cancer
06/06/2012CN101953998B Chinese medicinal powder for treating laryngitis and preparation method thereof
06/06/2012CN101856438B Medicinal composition for treating infant asthma and preparation method and use thereof
06/06/2012CN101849902B Preparation method of solid pharmaceutical composition containing desloratadine
06/06/2012CN101791325B Preparation method of Chinese goosebeery capsule for preventing and treating lung cancer
06/06/2012CN101791313B Application of calcium disodium edentate and corticosteroid compound preparation in preparing medicine capable of inhibiting connective tissue growth factors and monoamine oxidase
06/06/2012CN101698023B Chinese herbal medicine formula for treating asthma
06/06/2012CN101638404B High-purity salvianolic acid B and preparation method and application thereof
06/06/2012CN101623391B Medicine for treating acute and chronic tonsillitis and preparation method thereof
06/06/2012CN101611920B Method for preparing chrysanthemum health-care cigarette instead of tobacco
06/06/2012CN101530461B Traditional Chinese medicine for treating nasopharyngeal cancer
06/06/2012CN101511369B Methods and compositions for inhibiting angiogenesis.
06/06/2012CN101455697B Medicine for treating cough and preparation method and use thereof
06/06/2012CN101444570B Niuhuangshangqing soft capsule and preparation method thereof
06/06/2012CN101416964B Use of sophocarpine in preparing medicine for treating diseases induced by coxsackie B virus
06/06/2012CN101213187B Isoquinoline derivatives as inhibitors of RHO-kinase
06/05/2012US8193356 Heterocycle compound, and production process and application thereof
06/05/2012US8193164 Organic compounds
06/05/2012CA2557275C Bicyclo derivative
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
06/05/2012CA2368670C Modulation of vascular permeability by means of tie2 receptor activators
05/2012
05/31/2012WO2012069275A1 Glycine derivatives and their use as muscarinic receptor antagonists
05/31/2012WO2012069175A1 New pyrazole derivatives having crth2 antagonistic behaviour
05/31/2012WO2012048059A3 Bepotastine compositions
05/31/2012WO2012047017A3 2,3-dihydro-isoindol-1-one derivative and a composition comprising the same
05/31/2012WO2012033789A3 Treatment of diseases
05/31/2012WO2012033348A3 Composition for the prevention or treatment of allergic diseases comprising 2-linoleoyl glycerol
05/31/2012WO2012007729A3 Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators
05/31/2012US20120137379 Novel aav's and uses thereof
05/31/2012US20120136157 Aryl ureas as kinase inhibitors
05/31/2012US20120136044 Compositions And Methods Of Inhibiting NADPH Oxidase Expression
05/31/2012US20120136034 Fatty acids as anti-inflammatory agents
05/31/2012US20120136031 P38map kinase inhibitor
05/31/2012US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120136013 Organic compounds
05/31/2012US20120136006 Cold menthol receptor antagonists
05/31/2012US20120136000 Tri-cyclic pyrazolopyridine kinase inhibitors
05/31/2012US20120135998 Compounds for treating respiratory syncytial virus infections
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135985 Substituted piperidines
05/31/2012US20120135984 Dual-action inhbitors and methods of using same
05/31/2012US20120135982 5HT2c RECEPTOR MODULATORS
05/31/2012US20120135975 Substituted Esters as Cannabinoid-1 Receptor Modulators
05/31/2012US20120135971 Estrogen antagonists as treatments for sclerosing disorders
05/31/2012US20120135970 Compositions for preventing and treating an immune system disorder
05/31/2012US20120135969 Novel powdered crystalline medicines for inhalation
05/31/2012US20120135964 Certain chemical entities, compositions, and methods
05/31/2012US20120135956 Compositions for preventing and treating an immune system disorder
05/31/2012US20120135947 Oil-in-water emulsion composition containing difluprednate and tobramycin
05/31/2012US20120135932 Compositions And Methods For Treating Ischemia And Ischemia-Reperfusion Injury
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135067 Vaccine for mycoplasma infection
05/31/2012US20120135066 Regulators of the hedgehog pathway, compositions and uses related thereto
05/31/2012US20120135055 Dry Powder Inhaler Formulations
05/31/2012US20120135041 Immunosuppressor based on the blockage of tcr-nck interaction
05/31/2012US20120135016 Induction of neurogenesis and stem cell therapy in combination with copolymer 1
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/31/2012US20120135006 Ultra high affinity neutralizing antibodies
05/31/2012US20120134998 Secreted ap2 and methods of inhibiting same
05/31/2012US20120134935 Use of mometasone furoate for treating airway passage and lung disease
05/31/2012US20120134934 Glycine derivatives and medicinal compositions thereof
05/31/2012US20120132204 Unit dose dry powder inhaler
05/31/2012CA2820600A1 Glycine derivatives and their use as muscarinic receptor antagonists
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 878